Assessing the adherence of large language models to clinical practice guidelines in Chinese medicine: a content analysis

评估大型语言模型对中医临床实践指南的遵循情况:一项内容分析

阅读:2

Abstract

OBJECTIVE: Whether large language models (LLMs) can effectively facilitate CM knowledge acquisition remains uncertain. This study aims to assess the adherence of LLMs to Clinical Practice Guidelines (CPGs) in CM. METHODS: This cross-sectional study randomly selected ten CPGs in CM and constructed 150 questions across three categories: medication based on differential diagnosis (MDD), specific prescription consultation (SPC), and CM theory analysis (CTA). Eight LLMs (GPT-4o, Claude-3.5 Sonnet, Moonshot-v1, ChatGLM-4, DeepSeek-v3, DeepSeek-r1, Claude-4 sonnet, and Claude-4 sonnet thinking) were evaluated using both English and Chinese queries. The main evaluation metrics included accuracy, readability, and use of safety disclaimers. RESULTS: Overall, DeepSeek-v3 and DeepSeek-r1 demonstrated superior performance in both English (median 5.00, interquartile range (IQR) 4.00-5.00 vs. median 5.00, IQR 3.70-5.00) and Chinese (both median 5.00, IQR 4.30-5.00), significantly outperforming all other models. All models achieved significantly higher accuracy in Chinese versus English responses (all p < 0.05). Significant variations in accuracy were observed across the categories of questions, with MDD and SPC questions presenting more challenges than CTA questions. English responses had lower readability (mean flesch reading ease score 32.7) compared to Chinese responses. Moonshot-v1 provided the highest rate of safety disclaimers (98.7% English, 100% Chinese). CONCLUSION: LLMs showed varying degrees of potential for acquiring CM knowledge. The performance of DeepSeek-v3 and DeepSeek-r1 is satisfactory. Optimizing LLMs to become effective tools for disseminating CM information is an important direction for future development.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。